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RESUMO – ,QWURGXomR A prática da telemedicina em geral e teledermatologia em particular tem sido objecto de crescente 
interesse dada a evolução tecnológica dos equipamentos, os potenciais benefícios a nível dos custos em saúde, melhoria das 
listas de espera e a capacidade de prestar cuidados especializados a um maior número de doentes. O principal objectivo 
deste estudo foi avaliar a acuidade diagnóstica e a fiabilidade de uma consulta presencial quando comparada com uma te-
leconsulta do tipo armazenamento e envio no diagnóstico de lesões únicas suspeitas. 0DWHULDOH0pWRGRV Foi realizado um 
estudo retrospectivo de todos os doentes observados no projecto-piloto estabelecido entre o Serviço de Dermatovenereologia 
do Hospital Garcia de Orta e 5 centro de saúde da área de influência no período de Junho a Dezembro de 2016. O pro-
jecto consistia na referenciação de uma lesão suspeita pelo médico de Medicina Geral e Familiar através do envio de uma 
fotografia macroscópica acompanhada de uma breve informação clínica. A todas as lesões era atribuído um telediagnóstico, 
seguido de uma consulta presencial realizada pelo mesmo dermatologista. O diagnóstico-padrão utilizado para a medição 
da acuidade diagnóstica foi o diagnóstico histopatológico, ou, nalguns casos de lesões benignas, o diagnóstico clínico e der-
matoscópico. 5HVXOWDGRV Foi incluído um total de 68 doentes, correspondente a 68 lesões, 31 (46%) mulheres e 37 (54%) 
homens. A idade média foi de 67 anos, com uma idade média mais baixa no subrupo dos doentes do género masculino 
(52 vs 88 anos). As lesões malignas e pré-malignas corresponderam a 53% dos casos. A concordância diagnóstica foi de 
54%. A consulta presencial mostrou uma melhor acuidade diagnóstica quando comparada com a teleconsulta (85% vs 77%). 
&RQFOXVmR Este estudo ilustra o potencial da teleconsulta do tipo envio e armazenamento no diagnóstico de lesões cutâneas 
suspeitas referenciadas dos cuidados primários.  
PALAVRAS-CHAVE – Neoplasias da Pele/diagnóstico; Telemedicina.
Experience of a Pilot Project of Teledermatology 
Screening at the Department of Dermatology and 
Venereology of Hospital Garcia de Orta   
ABSTRACT – ,QWURGXFWLRQ The practice of telemedicine in general and teledermatology in particular has been gaining renewed 
interest given the technologically improved equipment, the potential benefits in terms of costs and waiting times and the ability 
to deliver specialised healthcare to more patients. The main aim of the study was to assess the diagnostic reliability and accuracy 
of a face-to-face consultation compared with store-and-forward teleconsultation in clinically suspicious solitary lesions. Material 
DQG0HWKRGV This is a retrospective study of all the patients included in a pilot project between Dermatology Department at 
Hospital Garcia de Orta and 5 regionally-dependent health centres from June to December 2016. It consisted in the referral of 
a clinically suspicious solitary lesion photograph by the general practitioner with a short clinical information. All the lesions were 
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INTRODUCTION
It is well known that early diagnosis and treatment of 
skin cancer improves prognosis.1 As rates of skin cancer 
are increasing,1 there is a growing concern about the time-
ly delivery of health care both in rural and urban areas. In 
this regard, teledermatolgy could be a valuable tool in tria-
ge referrals, reducing time to diagnosis and time to treat-
ment of malignant cutaneous lesions. 
Telemedicine relies on the use of technology of commu-
nication for exchanging expert medical information. Since 
the Dermatology is an especially telemedicine-prone field 
given the importance of its visual component, there is a 
growing interest in the potential, feasibility and reliability 
of teledermatology.
The two most common types of teledermatology are 
store-and-forward consultation, which involves transfer of 
clinical data to be evaluated at another location and time 
and real-time (or interactive) consultation.2 The former has 
several advantages including lower costs, use of less com-
plex equipment and less time-consuming consultations.2
Nevertheless, before implementing new modes of 
health care practices, it is important to establish its diag-
nostic accuracy. In the particular case of skin cancer, is it 
important to compare the diagnostic accuracy between a 
store-and-forward consultation and a face-to face-con-
sultation.
MATERIAL AND METHODS
We retrospectively analysed all the clinically suspicious 
solitary lesions referred to our Teledermatology department 
by the general practicioners from five regionally linked 
health centres between June and December 2016, in a 
weekly consultation with 1 to 2 hours duration. All refer-
rals were performed with a macroscopic photograph of the 
entire lesion, some of them including a ruler in the image, 
accompanied by brief clinical information which included 
demographic data, relevant personal and family clinical 
history, lesion duration and evolution (Figs.1 and 2).
All referrals were assigned a teleconsultation diagnosis 
and a face-to-face diagnosis, performed by the same der-
matologist. 
The reference-standard was the histopathologic result, 
or in some cases of benign straightforward lesions, the cli-
nical and dermoscopic diagnosis.
RESULTS
Between June and December 2016, from a total of 
103 referrals, 68 patients were included. The exclusion 
criteria were missing or low-quality photograph (n=19 - 
18.4%)), multiple lesions not suitable for the category of 
solitary suspicious lesion (n=12 - 11.6%) and inability to 
attend the face-to-face consultation (n=4 - 3.8%). From 
the total of patients included, 31 (46%) were female and 
37 (54%) male. The mean age of the population was 67 
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assigned a telediagnosis, followed by a face-to-face consultation performed by the same dermatologist. The gold-standard for 
measuring diagnostic accuracy was the histopathological diagnosis and, in some cases of benign straightforward lesions, the 
clinical and dermoscopic diagnosis performed by the dermatologist. 5HVXOWV A total of 68 patients, corresponding to a total of 
68 lesions, were included in the study, 31(46%) female and 37 (54%) male patients. The mean age was 67 years, with a lower 
mean age in the male group (52 versus 88 years). 53% of cases corresponded to malignant and pre-malignant lesions. The 
diagnostic concordance was 84%. Face-to-face consultation showed a better diagnostic accuracy than teleconsultation (85% vs 
77%). &RQFOXVLRQ This study illustrates the potential of teledermatology to diagnose clinically suspicious solitary lesions referred 
from primary care.
KEYWORDS – Skin Neoplasms/diagnosis; Telemedicine.
Figure 1 - Referral macroscopic photograph of pigmented lesion on 
the leg of a 54-year-old male patient.
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years, ranging between 25 and 91 years. The mean age 
in the female group was 88 years compared to 52 years in 
male patients group.
Benign lesions accounted for 47% of diagnoses in our 
study, with 53% corresponding to malignant and pre-ma-
lignant lesions. The most common referred benign lesions 
included seborrheic keratoses (13%), melanocytic nevi (9%) 
and hemangiomas (5%). Other benign lesions referred 
were keloid scars and viral warts. 
The most frequently diagnosed malignant or pre-ma-
lignant lesions were basal cell carcinomas (25%), actinic 
keratoses (15%), squamous cell carcinomas (7%) and ma-
lignant melanoma (6%). 
The reference-standard for diagnosis used was the his-
topathological result in 55% of cases and the clinical and 
dermoscopic diagnosis in cases of benign straightforward 
lesions, which occurred in 45% of cases, assuming a diag-
nostic concordance of 100% in these cases.
The diagnostic accuracy for suspicious lesions measu-
red as the concordance of the clinical diagnosis compared 
to the reference-standard was 77% for teledermatology 
and 85% for face-to-face consultations. 
The diagnostic concordance between the teledermato-
logy diagnosis and face-to-face diagnosis was 84%.
The mean time to face-to-face diagnosis was 54 days in 
the pilot study compared to 139 days in the conventional 
referral system. 
DISCUSSION
The aim of this study represents a proof-of-concept and 
it does not reflect the current scenario of teledermatology in 
the national healthcare setting. In this study we were able 
to measure only some of the intermediate clinical outcomes 
such as the diagnostic concordance between a face-to-face 
consultation and a store-and-forward consultation in suspi-
cious solitary skin lesions. We managed to show a good clini-
cal diagnostic concordance of 84% between teledermatology 
and face-to-face consultations and an acceptable diagnostic 
accuracy for teledermatology compared to face-to-face con-
sultation (77% vs 85%), the results being similar to other stu-
dies.3-7 Nevertheless we have to point out that 18.4% of cases 
had to be excluded by the bad quality of the photos, which 
represents a significant drawback. 
Another important issue we were able to address was the 
missed malignant diagnoses by the referral physician. In four 
patients (6%) a secondary malignant lesion (in all cases a 
basal cell carcinoma) was detected on clinical inspection. 
From a total of 10 melanocytic lesions referred, only 
five were considered atypical by the dermatologist, and 
four were malignant melanoma.
The study also contributes to our understanding of the 
referral patterns from the primary care. Almost half of re-
ferral diagnoses corresponded to benign lesions, some of 
which could otherwise have been managed in the primary 
care setting, improving the waiting times and, consequen-
tly, the early diagnosis and treatment of malignant lesions. 
As this was a proof-of-concept study, it did not address 
issues such as differences in treatment options and the real 
effect on waiting lists. This drawback resulted from the de-
sign itself since all the patients were scheduled for a face-
-to-face consultation, leading to the inability to measure 
time till diagnosis and time till treatment of teledermato-
logy-based referrals when compared with the traditional 
referral system. This is an important issue to be addressed 
in future investigations. 
Furthermore, it would be of paramount importance to as-
sess the performance of teledermatology in diagnosing and 
managing inflammatory dermatoses before we can establish 
its value in delivering timely, good standard health care. 
It is important to notice that when evaluating teleder-
matology systems, the clinical outcomes are measured 
in terms of number of consultations avoided, time to in-
tervention and consultation time, which are intermediate 
outcomes, instead of representing fundamental clinical 
endpoints, such as mortality, morbidity, quality of life and 
others. From this point of view, there is not much data avai-
lable comparing a full teledermatology consultation com-
pared to teledermatology as a complement tool to clinical 
decision-making.
CONCLUSION
In conclusion, teledermatology could improve accessi-
bility to healthcare in geographically remote areas and im-
prove standards of care in demographically denser areas. 
Nevertheless, there is a fundamental difference between 
the concept of teledermatology-assisted triage system and 
telemedicine consultations. Despite the strong visual com-
ponent inherent to Dermatology as a medical specialty, 
the conduction of a full teledermatology consultation is 
error-prone for various reasons and can hardly substitute 
a face-to-face consultation. The teledermatology-assisted 
triage system, on the other hand, seems an effective instru-
ment to be integrated in the clinical practice.7
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Figure 2 - Referral macroscopic photograph of a pigmented lesion on 
the trunk of a 61-year-old female patient.
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There are several requirements for an optimal implemen-
tation of teledermatology, namely, the education of profes-
sional involved in order to acquire role-specific competences 
such as patient selection, teledermatology diagnosis training, 
obtaining high-quality photographs and using relevant clini-
cal data in the referrals. There is also the need to continuou-
sly monitorize and audit the practice of teledermatology in 
terms of patient outcomes healthcare standards met. 
Much more research is needed into all levels of out-
comes and limitations of such a service and its effects on 
intermediate and endpoint clinical outcomes, since the 
purpose of any clinical instrument, in the optimal setting, is 
to improve patient care and elevate healthcare standards.
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